{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T03:20:54Z","timestamp":1791084054269,"version":"4.1.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,3,27]],"date-time":"2018-03-27T00:00:00Z","timestamp":1522108800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gene Ther"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1038\/s41434-018-0003-1","type":"journal-article","created":{"date-parts":[[2018,4,4]],"date-time":"2018-04-04T02:37:15Z","timestamp":1522809435000},"page":"139-156","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":56,"title":["Targeted in vivo knock-in of human alpha-1-antitrypsin cDNA using adenoviral delivery of CRISPR\/Cas9"],"prefix":"10.1038","volume":"25","author":[{"given":"Calvin J.","family":"Stephens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Kashentseva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Everett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyudmila","family":"Kaliberova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David T.","family":"Curiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,27]]},"reference":[{"key":"3_CR1","doi-asserted-by":"publisher","first-page":"10379","DOI":"10.1073\/pnas.96.18.10379","volume":"96","author":"T Vanden-Driessche","year":"1999","unstructured":"Vanden-Driessche T, Vanslembrouck V, Goovaerts I, Zwinnen H, Vanderhaeghen ML, Collen D, et al. Long-term expression of human coagulation factor VIII and correction of hemophilia A after in vivo retroviral gene transfer in factor VIII-deficient mice. Proc Natl Acad Sci USA. 1999;96:10379\u201384.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3_CR2","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1016\/j.ymthe.2017.07.002","volume":"25","author":"R Tran","year":"2017","unstructured":"Tran R, Myers DR, Denning G, Shields JE, Lytle AM, Alrowais H, et al. Microfluidic transduction harnesses mass transport principles to enhance gene transfer efficiency. Mol Ther. 2017;25:2372\u201382.","journal-title":"Mol Ther"},{"key":"3_CR3","doi-asserted-by":"publisher","first-page":"15025","DOI":"10.1038\/mtm.2015.25","volume":"2","author":"P Hu","year":"2015","unstructured":"Hu P, Li Y, Sands MS, McCown T, Kafri T. Generation of a stable packaging cell line producing high-titer PPT-deleted integration-deficient lentiviral vectors. Mol Ther Methods Clin Dev. 2015;2:15025.","journal-title":"Mol Ther Methods Clin Dev"},{"key":"3_CR4","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1038\/mt.2014.3","volume":"22","author":"D Cesana","year":"2014","unstructured":"Cesana D, Ranzani M, Volpin M, Bartholomae C, Duros C, Artus A, et al. Uncovering and dissecting the genotoxicity of self-inactivating lentiviral vectors in vivo. Mol Ther. 2014;22:774\u201385.","journal-title":"Mol Ther"},{"key":"3_CR5","doi-asserted-by":"publisher","first-page":"227ra33","DOI":"10.1126\/scitranslmed.3007280","volume":"6","author":"CJ Braun","year":"2014","unstructured":"Braun CJ, Boztug K, Paruzynski A, Witzel M, Schwarzer A, Rothe M, et al. Gene therapy for Wiskott-Aldrich syndrome\u2014long-term efficacy and genotoxicity. Sci Transl Med. 2014;6:227ra33.","journal-title":"Sci Transl Med"},{"key":"3_CR6","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1038\/gt.2008.55","volume":"15","author":"RH Smith","year":"2008","unstructured":"Smith RH. Adeno-associated virus integration: virus versus vector. Gene Therapy. 2008;15:817\u201322.","journal-title":"Gene Therapy"},{"key":"3_CR7","doi-asserted-by":"publisher","first-page":"7875","DOI":"10.1128\/JVI.00649-08","volume":"82","author":"M Penaud-Budloo","year":"2008","unstructured":"Penaud-Budloo M, Le Guiner C, Nowrouzi A, Toromanoff A, Ch\u00e9rel Y, Chenuaud P, et al. Adeno-associated virus vector genomes persist as episomal chromatin in primate muscle. J Virol. 2008;82:7875\u201385.","journal-title":"J Virol"},{"key":"3_CR8","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1056\/NEJMoa1407309","volume":"2014","author":"AC Nathwani","year":"2014","unstructured":"Nathwani AC, Reiss UM, Tuddenham EG, Rosales C, Chowdary P, McIntosh J, et al. Long-term safety and efficacy of factor IX gene therapy in hemophilia B. N Engl J Med. 2014;2014:1994\u20132004.","journal-title":"N Engl J Med"},{"key":"3_CR9","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/nm1358","volume":"12","author":"CS Manno","year":"2006","unstructured":"Manno CS, Pierce GF, Arruda VR, Glader B, Ragni M, Rasko JJ, et al. Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response. Nat Med. 2006;12:342\u20137.","journal-title":"Nat Med"},{"key":"3_CR10","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1089\/hum.2016.172","volume":"28","author":"HC Ertl","year":"2017","unstructured":"Ertl HC, High KA. Impact of AAV capsid-specific T-cell responses on design and outcome of clinical gene transfer trials with recombinant adeno-associated viral vectors: An evolving controversy. Hum Gene Ther. 2017;28:328\u201337.","journal-title":"Hum Gene Ther"},{"key":"3_CR11","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/nature10177","volume":"475","author":"H Li","year":"2011","unstructured":"Li H, Haurigot V, Doyon Y, Li T, Wong SY, Bhagwat AS, et al. In vivo genome editing restores hemostasis in a mouse model of hemophilia. Nature. 2011;475:217\u201321.","journal-title":"Nature"},{"key":"3_CR12","doi-asserted-by":"publisher","first-page":"477","DOI":"10.15252\/emmm.201506039","volume":"8","author":"Y Guan","year":"2016","unstructured":"Guan Y, Ma Y, Li Q, Sun Z, Ma L, Wu L, et al. CRISPR\/Cas9\u2010mediated somatic correction of a novel coagulator factor IX gene mutation ameliorates hemophilia in mouse. EMBO Mol Med. 2016;8:477\u201388.","journal-title":"EMBO Mol Med"},{"key":"3_CR13","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1182\/blood.V128.22.1174.1174","volume":"122","author":"L Wang","year":"2016","unstructured":"Wang L, Yang Y, White J, McMenamin D, Bell P, Wilson JM. CRISPR\/Cas9-mediated in vivo gene targeting corrects haemostasis in newborn and adult FIX-KO mice. Blood. 2016;122:1174.","journal-title":"Blood"},{"key":"3_CR14","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1038\/nature13864","volume":"517","author":"A Barzel","year":"2015","unstructured":"Barzel A, Paulk NK, Shi Y, Huang Y, Chu K, Zhang F, et al. Promoterless gene targeting without nucleases ameliorates haemophilia B in mice. Nature. 2015;517:360\u20134.","journal-title":"Nature"},{"key":"3_CR15","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1182\/blood-2014-12-615492","volume":"126","author":"R Sharma","year":"2015","unstructured":"Sharma R, Anguela XM, Doyon Y, Wechsler T, DeKelver RC, Sproul S, et al. In vivo genome editing of the albumin locus as a platform for protein replacement therapy. Blood. 2015;126:1777\u201384.","journal-title":"Blood"},{"key":"3_CR16","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/nbt.3471","volume":"34","author":"H Yin","year":"2016","unstructured":"Yin H, Song CQ, Dorkin JR, Zhu LJ, Li Y, Wu Q, et al. Therapeutic genome editing by combined viral and non-viral delivery of CRISPR system components in vivo. Nat Biotechnol. 2016;34:328\u201333.","journal-title":"Nat Biotechnol"},{"key":"3_CR17","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1126\/science.aad5143","volume":"351","author":"CE Nelson","year":"2016","unstructured":"Nelson CE, Hakim CH, Ousterout DG, Thakore PI, Moreb EA, Rivera RMC, et al. In vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy. Science. 2016;351:403\u20137.","journal-title":"Science"},{"key":"3_CR18","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1089\/hum.2013.2527","volume":"25","author":"RG Crystal","year":"2014","unstructured":"Crystal RG. Adenovirus: the first effective in vivo gene delivery vector. Hum Gene Ther. 2014;25:3\u201311.","journal-title":"Hum Gene Ther"},{"key":"3_CR19","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1089\/hum.1993.4.4-403","volume":"4","author":"Q Li","year":"1993","unstructured":"Li Q, Kay MA, Finegold M, Stratford-Perricaudet LD, Woo SL. Assessment of recombinant adenoviral vectors for hepatic gene therapy. Hum Gene Ther. 1993;4:403\u20139.","journal-title":"Hum Gene Ther"},{"key":"3_CR20","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.virol.2006.03.042","volume":"351","author":"LP Le","year":"2006","unstructured":"Le LP, Le HN, Nelson AR, Matthews DA, Yamamoto M, Curiel DT. Core labeling of adenovirus with EGFP. Virology. 2006;351:291\u2013302.","journal-title":"Virology"},{"key":"3_CR21","doi-asserted-by":"crossref","first-page":"4805","DOI":"10.1128\/JVI.70.7.4805-4810.1996","volume":"70","author":"C Chartier","year":"1996","unstructured":"Chartier C, Degryse E, Gantzer M, Dieterle A, Pavirani A, Mehtali M. Efficient generation of recombinant adenovirus vectors by homologous recombination in Escherichia coli. J Virol. 1996;70:4805\u201310.","journal-title":"J Virol"},{"key":"3_CR22","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/0042-6822(68)90121-9","volume":"36","author":"JV Maizel","year":"1968","unstructured":"Maizel JV, David WO, Scharff MD. The polypeptides of adenovirus: I. Evidence for multiple protein components in the virion and a comparison of types 2, 7A, and 12. Virology. 1968;36:115\u201325.","journal-title":"Virology"},{"key":"3_CR23","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1038\/nmeth1103","volume":"4","author":"M Schmidt","year":"2007","unstructured":"Schmidt M, Schwarzwaelder K, Bartholomae C, Zaoui K, Ball C, Pilz I, et al. High-resolution insertion-site analysis by linear amplification-mediated PCR (LAM-PCR). Nat Methods. 2007;4:1051\u20137.","journal-title":"Nat Methods"},{"key":"3_CR24","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.virol.2013.09.020","volume":"447","author":"SA Kaliberov","year":"2013","unstructured":"Kaliberov SA, Kaliberova LN, Lu ZH, Preuss MA, Barnes JA, Stockard CR, et al. Retargeting of gene expression using endothelium specific hexon modified adenoviral vector. Virology. 2013;447:312\u201325.","journal-title":"Virology"},{"key":"3_CR25","first-page":"207","volume":"17","author":"J Kieleczawa","year":"2006","unstructured":"Kieleczawa J. Fundamentals of sequencing of difficult templates\u2014an overview. J Biomol Technol. 2006;17:207.","journal-title":"J Biomol Technol"},{"key":"3_CR26","doi-asserted-by":"crossref","first-page":"8902","DOI":"10.1128\/JVI.71.11.8902-8907.1997","volume":"71","author":"JE Nelson","year":"1997","unstructured":"Nelson JE, Kay MA. Persistence of recombinant adenovirus in vivo is not dependent on vector DNA replication. J Virol. 1997;71:8902\u20137.","journal-title":"J Virol"},{"key":"3_CR27","doi-asserted-by":"publisher","first-page":"7689","DOI":"10.1128\/JVI.77.13.7689-7695.2003","volume":"77","author":"A Ehrhardt","year":"2003","unstructured":"Ehrhardt A, Xu H, Kay MA. Episomal persistence of recombinant adenoviral vector genomes during the cell cycle in vivo. J Virol. 2003;77:7689\u201395.","journal-title":"J Virol"},{"key":"3_CR28","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1089\/hum.1992.3.6-641","volume":"3","author":"MA Kay","year":"1992","unstructured":"Kay MA, Li Q, Liu TJ, Leland F, Toman C, Finegold M, et al. Hepatic gene therapy: persistent expression of human \u03b11-antitrypsin in mice after direct gene delivery in vivo. Hum Gene Ther. 1992;3:641\u20137.","journal-title":"Hum Gene Ther"},{"key":"3_CR29","doi-asserted-by":"crossref","unstructured":"Charlesworth CT, Deshpande PS, Dever DP, Dejene B, Gomez-Ospina N, Mantri S et al. Identification of pre-existing adaptive immunity to Cas9 proteins in humans. bioRxiv 2018; 243345.","DOI":"10.1101\/243345"},{"key":"3_CR30","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1038\/nmeth.3993","volume":"13","author":"WL Chew","year":"2016","unstructured":"Chew WL, Tabebordbar M, Cheng JK, Mali P, Wu EY, Ng AH, et al. A multifunctional AAV-CRISPR-Cas9 and its host response. Nat Methods. 2016;13:868\u201374.","journal-title":"Nat Methods"},{"key":"3_CR31","doi-asserted-by":"publisher","first-page":"9987","DOI":"10.1128\/JVI.00751-10","volume":"84","author":"SL Stephen","year":"2010","unstructured":"Stephen SL, Montini E, Sivanandam VG, Al-Dhalimy M, Kestler HA, Finegold M, et al. Chromosomal integration of adenoviral vector DNA in vivo. J Virol. 2010;84:9987\u201394.","journal-title":"J Virol"},{"key":"3_CR32","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1089\/hum.2016.134","volume":"28","author":"N Dronadula","year":"2017","unstructured":"Dronadula N, Wacker BK, Van Der Kwast R, Zhang J, Dichek DA. Stable in vivo transgene expression in endothelial cells with helper-dependent adenovirus: roles of promoter and interleukin-10. Hum Gene Ther. 2017;28:255\u201370.","journal-title":"Hum Gene Ther"},{"key":"3_CR33","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.omtm.2017.07.001","volume":"6","author":"S Iizuka","year":"2017","unstructured":"Iizuka S, Sakurai F, Tachibana M, Ohashi K, Mizuguchi H. Neonatal gene therapy for hemophilia B by a novel adenovirus vector showing reduced leaky expression of viral genes. Mol Ther Methods Clin Dev. 2017;6:183\u201393.","journal-title":"Mol Ther Methods Clin Dev"},{"key":"3_CR34","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1128\/JVI.78.1.9-22.2004","volume":"78","author":"F Kreppel","year":"2004","unstructured":"Kreppel F, Kochanek S. Long-term transgene expression in proliferating cells mediated by episomally maintained high-capacity adenovirus vectors. J Virol. 2004;78:9\u201322.","journal-title":"J Virol"},{"key":"3_CR35","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1038\/cr.2017.76","volume":"27","author":"X Yao","year":"2017","unstructured":"Yao X, Wang X, Hu X, Liu Z, Liu J, Zhou H, et al. Homology-mediated end joining-based targeted integration using CRISPR\/Cas9. Cell Res. 2017;27:801\u201314.","journal-title":"Cell Res"},{"key":"3_CR36","doi-asserted-by":"publisher","first-page":"5560","DOI":"10.1038\/ncomms6560","volume":"5","author":"S Nakade","year":"2014","unstructured":"Nakade S, Tsubota T, Sakane Y, Kume S, Sakamoto N, Obara M, et al. Microhomology-mediated end-joining-dependent integration of donor DNA in cells and animals using TALENs and CRISPR\/Cas9. Nat Commun. 2014;5:5560.","journal-title":"Nat Commun"},{"key":"3_CR37","doi-asserted-by":"publisher","first-page":"4850","DOI":"10.1172\/JCI59261","volume":"121","author":"Y Malato","year":"2011","unstructured":"Malato Y, Naqvi S, Sch\u00fcrmann N, Ng R, Wang B, Zape J, et al. Fate tracing of mature hepatocytes in mouse liver homeostasis and regeneration. J Clin Invest. 2011;121:4850.","journal-title":"J Clin Invest"},{"key":"3_CR38","unstructured":"Tolmachov OE, Subkhankulova T, Tolmachova T. Silencing of transgene expression: a gene therapy perspective. In: Francisco MM (ed). Gene therapy\u2014tools and potential applications. InTech; 2013."},{"key":"3_CR39","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/mtna.2013.47","volume":"2","author":"C Hagedorn","year":"2013","unstructured":"Hagedorn C, Antoniou M, Lipps HJ. Genomic cis-acting sequences improve expression and establishment of a nonviral vector. Mol Ther Nucleic Acids. 2013;2:118.","journal-title":"Mol Ther Nucleic Acids"},{"key":"3_CR40","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1038\/nbt1362","volume":"25","author":"S Irion","year":"2007","unstructured":"Irion S, Luche H, Gadue P, Fehling HJ, Kennedy M, Keller G. Identification and targeting of the ROSA26 locus in human embryonic stem cells. Nat Biotechnol. 2007;25:1477\u201382.","journal-title":"Nat Biotechnol"},{"key":"3_CR41","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/sj.gt.3301139","volume":"7","author":"DS Steinwaerder","year":"2003","unstructured":"Steinwaerder DS, Lieber A. Insulation from viral transcriptional regulatory elements improves inducible transgene expression from adenovirus vectors in vitro and in vivo. Gene Therapy. 2003;7:556.","journal-title":"Gene Therapy"},{"key":"3_CR42","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1038\/sj.mt.6300177","volume":"15","author":"E Riu","year":"2007","unstructured":"Riu E, Chen ZY, Xu H, He CY, Kay MA. Histone modifications are associated with the persistence or silencing of vector-mediated transgene expression in vivo. Mol Ther. 2007;15:1348\u201355.","journal-title":"Mol Ther"},{"key":"3_CR43","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1073\/pnas.97.1.377","volume":"97","author":"WY Chen","year":"2005","unstructured":"Chen WY, Townes TM. Molecular mechanism for silencing virally transduced genes involves histone deacetylation and chromatin condensation. Proc Natl Acad Sci USA. 2005;97:377\u201382.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3_CR44","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/nbt.3198","volume":"33","author":"VT Chu","year":"2015","unstructured":"Chu VT, Weber T, Wefers B, Wurst W, Sander S, Rajewsky K, et al. Increasing the efficiency of homology-directed repair for CRISPR-Cas9-induced precise gene editing in mammalian cells. Nat Biotechnol. 2015;33:543\u20138.","journal-title":"Nat Biotechnol"},{"key":"3_CR45","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1038\/nbt.3190","volume":"33","author":"T Maruyama","year":"2015","unstructured":"Maruyama T, Dougan SK, Truttmann M, Bilate AM, Ingram JR, Ploegh HL. Inhibition of non-homologous end joining increases the efficiency of CRISPR\/Cas9-mediated precise genome editing. Nat Biotechnol. 2015;33:538.","journal-title":"Nat Biotechnol"},{"key":"3_CR46","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1038\/mt.2016.105","volume":"24","author":"KS Gwiazda","year":"2016","unstructured":"Gwiazda KS, Grier AE, Sahni J, Burleigh SM, Martin U, Yang JG, et al. High efficiency CRISPR\/Cas9-mediated gene editing in primary human T-cells using mutant adenoviral E4orf6\/E1b55k \u201chelper\u201d proteins. Mol Ther. 2016;24:1570\u201380.","journal-title":"Mol Ther"},{"key":"3_CR47","doi-asserted-by":"publisher","first-page":"8105","DOI":"10.1093\/nar\/gkx497","volume":"45","author":"O Baker","year":"2017","unstructured":"Baker O, Tsurkan S, Fu J, Klink B, Rump A, Obst M, et al. The contribution of homology arms to nuclease-assisted genome engineering. Nucleic Acids Res. 2017;45:8105\u201315.","journal-title":"Nucleic Acids Res"},{"key":"3_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/srep23549","volume":"6","author":"Y Miyaoka","year":"2016","unstructured":"Miyaoka Y, Berman JR, Cooper SB, Mayerl SJ, Chan AH, Zhang B, et al. Systematic quantification of HDR and NHEJ reveals effects of locus, nuclease, and cell type on genome-editing. Sci Rep. 2016;6:23549.","journal-title":"Sci Rep"},{"key":"3_CR49","doi-asserted-by":"publisher","first-page":"3982","DOI":"10.1016\/j.febslet.2014.09.014","volume":"588","author":"P Kasparek","year":"2014","unstructured":"Kasparek P, Krausova M, Haneckova R, Kriz V, Zbodakova O, Korinek V, et al. Efficient gene targeting of the Rosa26 locus in mouse zygotes using TALE nucleases. FEBS Lett. 2014;588:3982\u20138.","journal-title":"FEBS Lett"},{"key":"3_CR50","doi-asserted-by":"publisher","first-page":"15464","DOI":"10.1038\/ncomms15464","volume":"8","author":"HY Shin","year":"2017","unstructured":"Shin HY, Wang C, Lee HK, Yoo KH, Zeng X, Kuhns T, et al. CRISPR\/Cas9 targeting events cause complex deletions and insertions at 17 sites in the mouse genome. Nat Commun. 2017;8:15464.","journal-title":"Nat Commun"},{"key":"3_CR51","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/nmeth.4293","volume":"14","author":"KA Schaefer","year":"2017","unstructured":"Schaefer KA, Wu WH, Colgan DF, Tsang SH, Bassuk AG, Mahajan VB. Unexpected mutations after CRISPR-Cas9 editing in vivo. Nat Methods. 2017;14:547\u20138.","journal-title":"Nat Methods"},{"key":"3_CR52","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1089\/10430349950018364","volume":"10","author":"DA Muruve","year":"1999","unstructured":"Muruve DA, Barnes MJ, Stillman IE, Libermann TA. Adenoviral gene therapy leads to rapid induction of multiple chemokines and acute neutrophil-dependent hepatic injury in vivo. Hum Gene Ther. 1999;10:965\u201376.","journal-title":"Hum Gene Ther"},{"key":"3_CR53","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1089\/hum.2017.009","volume":"28","author":"RJ Chandler","year":"2017","unstructured":"Chandler RJ, Sands MS, Venditti CP. Recombinant adeno-associated viral integration and genotoxicity: insights from animal models. Hum Gene Ther. 2017;28:314\u201322.","journal-title":"Hum Gene Ther"},{"key":"3_CR54","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1038\/ng.3389","volume":"47","author":"JC Nault","year":"2015","unstructured":"Nault JC, Datta S, Imbeaud S, Franconi A, Mallet M, Couchy G, et al. Recurrent AAV2-related insertional mutagenesis in human hepatocellular carcinomas. Nat Genet. 2015;47:1187\u201393.","journal-title":"Nat Genet"},{"key":"3_CR55","first-page":"442","volume":"11","author":"DR Deyle","year":"2009","unstructured":"Deyle DR, Russell DW. Adeno-associated virus vector integration. Curr Opin Mol Ther. 2009;11:442.","journal-title":"Curr Opin Mol Ther"},{"key":"3_CR56","doi-asserted-by":"crossref","first-page":"8429","DOI":"10.1128\/JVI.71.11.8429-8436.1997","volume":"71","author":"EA Rutledge","year":"1997","unstructured":"Rutledge EA, Russell DW. Adeno-associated virus vector integration junctions. J Virol. 1997;71:8429\u201336.","journal-title":"J Virol"},{"key":"3_CR57","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1126\/science.1142658","volume":"317","author":"A Donsante","year":"2007","unstructured":"Donsante A, Miller DG, Li Y, Vogler C, Brunt EM, Russell DW, et al. AAV vector integration sites in mouse hepatocellular carcinoma. Science. 2007;317:477\u2013477.","journal-title":"Science"},{"key":"3_CR58","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1038\/ng.3893","volume":"49","author":"GJ Logan","year":"2017","unstructured":"Logan GJ, Dane AP, Hallwirth CV, Smyth CM, Wilkie EE, Amaya AK, et al. Identification of liver-specific enhancer-promoter activity in the 3\u2019 untranslated region of the wild-type AAV2 genome. Nat Genet. 2017;49:1267.","journal-title":"Nat Genet"},{"key":"3_CR59","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.coviro.2016.08.017","volume":"21","author":"S Atasheva","year":"2016","unstructured":"Atasheva S, Shayakhmetov DM. Adenovirus sensing by the immune system. Curr Opin Virol. 2016;21:109\u201313.","journal-title":"Curr Opin Virol"},{"key":"3_CR60","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1089\/hum.2015.087","volume":"26","author":"D Wang","year":"2015","unstructured":"Wang D, Mou H, Li S, Li Y, Hough S, Tran K, et al. Adenovirus-mediated somatic genome editing of Pten by CRISPR\/Cas9 in mouse liver in spite of Cas9-specific immune responses. Hum Gene Ther. 2015;26:432\u201342.","journal-title":"Hum Gene Ther"},{"key":"3_CR61","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1038\/mtna.2016.99","volume":"5","author":"AG Kotini","year":"2016","unstructured":"Kotini AG, Sadelain M, Papapetrou EP. LiPS-A3S, a human genomic site for robust expression of inserted transgenes. Mol Ther Nucleic Acids. 2016;5:394","journal-title":"Mol Ther Nucleic Acids"},{"key":"3_CR62","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/nrc3179","volume":"12","author":"M Sadelain","year":"2012","unstructured":"Sadelain M, Papapetrou EP, Bushman FD. Safe harbours for the integration of new DNA in the human genome. Nat Rev Cancer. 2012;12:51\u201358.","journal-title":"Nat Rev Cancer"},{"key":"3_CR63","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1038\/nbt.3469","volume":"34","author":"Y Yang","year":"2016","unstructured":"Yang Y, Wang L, Bell P, McMenamin D, He Z, White J, et al. A dual AAV system enables the Cas9-mediated correction of a metabolic liver disease in newborn mice. Nat Biotechnol. 2016;34:334\u20138.","journal-title":"Nat Biotechnol"},{"key":"3_CR64","first-page":"1343","volume":"85","author":"RG Crystal","year":"1990","unstructured":"Crystal RG. Alpha 1-antitrypsin deficiency, emphysema, and liver disease. Genetic basis and strategies for therapy. J Clin Inst. 1990;85:1343.","journal-title":"J Clin Inst"},{"key":"3_CR65","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1038\/nmeth.3075","volume":"11","author":"M Holkers","year":"2014","unstructured":"Holkers M, Maggio I, Henriques SF, Janssen JM, Cathomen T, Gon\u00e7alves MA. Adenoviral vector DNA for accurate genome editing with engineered nucleases. Nat Methods. 2014;11:1051\u20137.","journal-title":"Nat Methods"},{"key":"3_CR66","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1182\/blood-2016-04-711580","volume":"128","author":"M Richter","year":"2016","unstructured":"Richter M, Saydaminova K, Yumul R, Krishnan R, Liu J, Nagy EE, et al. In vivo transduction of primitive mobilized hematopoietic stem cells after intravenous injection of integrating adenovirus vectors. Blood. 2016;128:2206\u201317.","journal-title":"Blood"},{"key":"3_CR67","first-page":"224","volume":"18","author":"CL Verweij","year":"1988","unstructured":"Verweij CL. Biosynthesis of human von Willebrand factor. Haemostasis. 1988;18:224\u201345.","journal-title":"Haemostasis"},{"key":"3_CR68","doi-asserted-by":"publisher","first-page":"3706","DOI":"10.1182\/blood-2014-02-555151","volume":"123","author":"SA Fahs","year":"2014","unstructured":"Fahs SA, Hille MT, Shi Q, Weiler H, Montgomery RR. A conditional knockout mouse model reveals endothelial cells as the principal and possibly exclusive source of plasma factor VIII. Blood. 2014;123:3706\u201313.","journal-title":"Blood"},{"key":"3_CR69","doi-asserted-by":"publisher","first-page":"23376","DOI":"10.1371\/journal.pone.0023376","volume":"6","author":"CM Chen","year":"2011","unstructured":"Chen CM, Krohn J, Bhattacharya S, Davies B. A comparison of exogenous promoter activity at the ROSA26 locus using a PhiC31 integrase mediated cassette exchange approach in mouse ES cells. PLoS ONE. 2011;6:23376.","journal-title":"PLoS ONE"},{"key":"3_CR70","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1089\/hum.2014.106","volume":"26","author":"PE Monahan","year":"2014","unstructured":"Monahan PE, Sun GJ, Gui T, Hu G, Hannah WB, Wichlan DG, et al. Employing a gain-of-function factor IX variant R338L to advance the efficacy and safety of hemophilia B human gene therapy: preclinical evaluation supporting an ongoing adeno-associated virus clinical trial. Hum Gene Ther. 2014;26:69\u201381.","journal-title":"Hum Gene Ther"},{"key":"3_CR71","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1111\/jth.13543","volume":"15","author":"GN Nguyen","year":"2017","unstructured":"Nguyen GN, George LA, Siner JI, Davidson RJ, Zander CB, Zheng XL, et al. Novel factor VIII variants with a modified furin cleavage site improve the efficacy of gene therapy for hemophilia A. J Thromb Haemost. 2017;15:110\u201321.","journal-title":"J Thromb Haemost"}],"container-title":["Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41434-018-0003-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41434-018-0003-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41434-018-0003-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:13:16Z","timestamp":1684617196000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41434-018-0003-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,27]]},"references-count":71,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["3"],"URL":"https:\/\/doi.org\/10.1038\/s41434-018-0003-1","relation":{},"ISSN":["0969-7128","1476-5462"],"issn-type":[{"value":"0969-7128","type":"print"},{"value":"1476-5462","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,27]]},"assertion":[{"value":"13 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}